Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov 22:14:762918.
doi: 10.3389/fnmol.2021.762918. eCollection 2021.

PrP C as a Transducer of Physiological and Pathological Signals

Affiliations
Review

PrP C as a Transducer of Physiological and Pathological Signals

Jessica D Panes et al. Front Mol Neurosci. .

Abstract

After the discovery of prion phenomenon, the physiological role of the cellular prion protein (PrP C ) remained elusive. In the past decades, molecular and cellular analysis has shed some light regarding interactions and functions of PrP C in health and disease. PrP C , which is located mainly at the plasma membrane of neuronal cells attached by a glycosylphosphatidylinositol (GPI) anchor, can act as a receptor or transducer from external signaling. Although the precise role of PrP C remains elusive, a variety of functions have been proposed for this protein, namely, neuronal excitability and viability. Although many issues must be solved to clearly define the role of PrP C , its connection to the central nervous system (CNS) and to several misfolding-associated diseases makes PrP C an interesting pharmacological target. In a physiological context, several reports have proposed that PrP C modulates synaptic transmission, interacting with various proteins, namely, ion pumps, channels, and metabotropic receptors. PrP C has also been implicated in the pathophysiological cell signaling induced by β-amyloid peptide that leads to synaptic dysfunction in the context of Alzheimer's disease (AD), as a mediator of Aβ-induced cell toxicity. Additionally, it has been implicated in other proteinopathies as well. In this review, we aimed to analyze the role of PrP C as a transducer of physiological and pathological signaling.

Keywords: Alzheimer’s disease; Aβ; PrP; PrPC in CNS; PrPC role; PrPC signaling.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
PrP structure. PrPC consists of 253 amino acids, which include the signal peptide (1–22), five octarepeat regions, a hydrophobic region (113–135), a disulfide bond between its cysteine residues 179 and 214, two N-glycosylation sites (residues 187 and 197), and a GPI anchor at its C-terminal. The structured conformation between amino acids 121 and 231 corresponds to a globular domain, which contains two β-sheets and three α-helices. (A) Linear representation of PrP sequence [modified from Acevedo-Morantes and Wille (2014)]. (B) PrP structure.
FIGURE 2
FIGURE 2
PrPC as a signal transducer. In the context of Alzheimer’s disease, the interaction between Aβ oligomers and PrPC affects receptors located on the plasmatic membrane, such as NMDAR and mGluR5. In the case of NMDAR, because of the interaction of Aβ oligomers and PrPC, the receptor is phosphorylated through Fyn, hyperactivating the channel and causing glutamatotoxicity. In the case of mGluR5, there is a direct interaction between PrPC and the receptor, causing the activation of Fyn kinase and promoting the phosphorylation of eEF2 and the consequent loss of neuritic spines.

References

    1. Acevedo-Morantes C. Y., Wille H. (2014). The structure of human prions: from biology to structural models-considerations and pitfalls. Viruses. 6 3875–3892. 10.3390/v6103875 - DOI - PMC - PubMed
    1. Alper T., Cramp W. A., Haig D. A., Clarke M. C. (1967). Does the agent of scrapie replicate without nucleic acid? Nature 214 764–766. 10.1038/214764a0 - DOI - PubMed
    1. Alvarez-Laviada A., Kadurin I., Senatore A., Chiesa R., Dolphin A. C. (2014). The inhibition of functional expression of calcium channels by prion protein demonstrates competition with alpha2delta for GPI-anchoring pathways. Biochem. J. 458 365–374. 10.1042/BJ20131405 - DOI - PMC - PubMed
    1. Aulic S., Masperone L., Narkiewicz J., Isopi E., Bistaffa E., Ambrosetti E., et al. (2017). Alpha-Synuclein amyloids hijack prion protein to gain cell entry, facilitate cell-to-cell spreading and block prion replication. Sci. Rep. 7:10050. 10.1038/s41598-017-10236-x - DOI - PMC - PubMed
    1. Avila J., Lucas J. J., Perez M., Hernandez F. (2004). Role of tau protein in both physiological and pathological conditions. Physiol. Rev. 84 361–384. - PubMed